Literature DB >> 2658083

Antiidiotype antibody therapy of B-cell lymphoma.

S L Brown1, R A Miller, R Levy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2658083

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Immunoglobulin idiotype expression in reactive lymphoid tissues and B-cell lymphomas.

Authors:  M Shiota; K Kitamura; M Noda; Y Kawanishi; S Hart; R A Miller; S Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

2.  Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.

Authors:  B C Lubahn; H M Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 3.  Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant.

Authors:  Joshua Brody; Ronald Levy
Journal:  Immunotherapy       Date:  2009-09       Impact factor: 4.196

4.  Experimental treatment of chronic lymphocytic leukemia with extracorporeal photochemotherapy. Initial observations.

Authors:  R M Knobler; R Pirker; E M Kokoschka; H Ludwig; W Linkesch; M Micksche
Journal:  Blut       Date:  1990-04

Review 5.  Monoclonal antibodies and superantigens: a novel therapeutic approach.

Authors:  T Kalland; M Dohlsten; P Lind; A Sundstedt; L Abrahmsén; G Hedlund; P Björk; P A Lando; M Björklund
Journal:  Med Oncol Tumor Pharmacother       Date:  1993

Review 6.  Targeting of superantigens.

Authors:  T Kalland; M Dohlsten; L Abrahmsén; G Hedlund; P Björk; P A Lando; A Sundstedt; E Akerblom; P Lind
Journal:  Cell Biophys       Date:  1993 Jan-Jun

7.  Induction of tumor immunity by intact irradiated leukemic B cells (BCL1) bearing a tumor-associated cell-surface idiotype and the costimulatory B7 molecule.

Authors:  S Morecki; S Levi; Y Puyesky; S Slavin
Journal:  Cancer Immunol Immunother       Date:  1995-10       Impact factor: 6.968

8.  2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA.

Authors:  Mitchell Ho; Ivor Royston; Alain Beck
Journal:  MAbs       Date:  2012-08-06       Impact factor: 5.857
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.